Last reviewed · How we verify
NCT07240831: PPG ABPM
Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)
NA trial testing Model BB-613WP in Blood Pressure in 600 participants. Not yet recruiting.
30 October 2026
Quick facts
| Lead sponsor | Biobeat Technologies Ltd. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 600 |
| Start date | 15 December 2025 |
| Primary completion | 30 October 2026 |
| Estimated completion | 30 October 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Model BB-613WP
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
- Heart Disease — all drugs for Heart Disease →
- Hypertension (HTN) — all drugs for Hypertension (HTN) →
- Blood Pressure Monitoring — all drugs for Blood Pressure Monitoring →
Sponsor
Biobeat Technologies Ltd.
Who can join
18 and older, any sex, with Blood Pressure or Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07240831
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other Biobeat Technologies Ltd. trials
Trials by the same sponsor.
- NCT04955184 — Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter · completed
- NCT04680039 — Early Warning of Intradialytic Hypotension in Hemodialysis Patients · completed
- NCT04635371 — Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor · completed
- NCT04548024 — Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients · completed
- NCT04220359 — Early Identification of Clinical Deterioration Using a Wearable Monitoring Device · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07240831 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biobeat Technologies Ltd.
- Last refreshed: 21 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07240831.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing